 Maravai Life Sciences Holdings NASDAQ:MRVI will hit the public markets with perfect timing as it sees its mRNA product used by COVID-19 vaccine makers. The Offering: Maravai Life Sciences plans on selling 50 million shares at a price point of 24 to 27. 